Yarrow blooms with $1.37B deal, landing autoimmune thyroid disease drug from China’s GenSci
Fuente:
FierceBiotech
U.S.-based Yarrow Bioscience is branching out, picking an autoimmune thyroid disease drug from China as its lead candidate.